Stockscreener 앱 받기
1.67
1.83%
0.03
시간 외 거래:
1.67
전일 마감가:
$1.64
열려 있는:
$1.63
하루 거래량:
22,654
Relative Volume:
0.07
시가총액:
$33.67M
수익:
$264.74M
순이익/손실:
$-49.71M
주가수익비율:
-0.4077
EPS:
-4.0959
순현금흐름:
$-43.55M
1주 성능:
+0.00%
1개월 성능:
+16.78%
6개월 성능:
-67.76%
1년 성능:
+317.50%
1일 변동 폭
$1.60
$1.76
1주일 범위
$1.55
$1.8199
52주 변동 폭
$1.305
$12.30
Camp 4 Therapeutics Corp Stock (CAMP) Company Profile
명칭
Camp 4 Therapeutics Corp
전화
617-651-8867
주소
ONE KENDALL SQUARE, CAMBRIDGE, CA
CAMP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CAMP
Camp 4 Therapeutics Corp
|
1.67 | 33.26M | 264.74M | -49.71M | -43.55M | -4.0959 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.98 | 118.67B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.90 | 59.23B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.91 | 52.67B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
674.90 | 41.24B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.23 | 32.36B | 3.81B | -644.79M | -669.77M | -6.24 |
Camp 4 Therapeutics Corp Stock (CAMP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-27 | 개시 | Wedbush | Outperform |
| 2024-11-05 | 개시 | JP Morgan | Overweight |
| 2024-11-05 | 개시 | Piper Sandler | Overweight |
| 2024-11-05 | 개시 | William Blair | Outperform |
| 2022-08-16 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2021-12-22 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2021-09-24 | 재확인 | Craig Hallum | Buy |
| 2021-06-25 | 재확인 | Craig Hallum | Buy |
| 2020-12-18 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-04-17 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-03-05 | 재확인 | Craig Hallum | Buy |
| 2019-12-20 | 재확인 | Craig Hallum | Buy |
| 2019-12-20 | 다운그레이드 | First Analysis Sec | Outperform → Neutral |
| 2019-06-28 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2019-05-29 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-05-01 | 재확인 | Craig Hallum | Buy |
| 2019-03-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-01-25 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-12-21 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2018-12-14 | 재확인 | B. Riley FBR | Buy |
| 2018-12-11 | 다운그레이드 | First Analysis Sec | Strong Buy → Outperform |
| 2018-12-11 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2018-11-27 | 개시 | Goldman | Neutral |
| 2018-10-15 | 개시 | Jefferies | Hold |
| 2018-09-28 | 재확인 | Craig Hallum | Hold |
| 2018-04-27 | 재확인 | Craig Hallum | Hold |
| 2018-03-08 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2018-02-16 | 업그레이드 | First Analysis Sec | Equal-Weight → Overweight |
모두보기
Camp 4 Therapeutics Corp 주식(CAMP)의 최신 뉴스
Pattern recognition hints at Camp4 Therapeutics Corporation upsideFree Daily Profit Focused Stock Screener - Newser
Published on: 2025-08-04 21:32:05 - metal.it
Risk vs reward if holding onto Camp4 Therapeutics CorporationPattern Breakout Tracker with Screener Tools - Newser
Using data filters to optimize entry into Camp4 Therapeutics CorporationChart Signal and Short-Term Forecast Tracker - Newser
Moving Average Trends for Camp4 Therapeutics Corporation Stock: What They IndicateHigh Return Trade Roadmap with Setup Filters - Newser
Should I hold or sell Camp4 Therapeutics Corporation stock in 2025Unbelievable profit margins - Jammu Links News
When is Camp4 Therapeutics Corporation stock expected to show significant growthRealize exceptional returns through smart trading - Jammu Links News
Why is Camp4 Therapeutics Corporation stock attracting strong analyst attentionFree Predictions - Jammu Links News
How sentiment analysis helps forecast Camp4 Therapeutics CorporationBull Market Summary and Recovery Outlook - newser.com
How many analysts rate Camp4 Therapeutics Corporation as a “Buy”High-profit capital plays - Jammu Links News
Camp4 Therapeutics Corporation Stock Analysis and ForecastMaximize returns with disciplined trading approaches - Jammu Links News
What is the dividend policy of Camp4 Therapeutics Corporation stockAchieve consistent profits with smart trading - Jammu Links News
What are the latest earnings results for Camp4 Therapeutics CorporationInvest smarter with cutting-edge analytics - Jammu Links News
What are analysts’ price targets for Camp4 Therapeutics Corporation in the next 12 monthsUnlock high-yield investment opportunities - Jammu Links News
Is Camp4 Therapeutics Corporation a good long term investmentGet alerts on high-potential stock breakouts - Jammu Links News
Published on: 2025-08-02 03:26:28 - Newser
How volatile is Camp4 Therapeutics Corporation stock compared to the marketAI Powered Strategy For Beginners - Jammu Links News
In Conversation with Josh Mandel-Brehm, CEO of CAMP4 Therapeutics - Inside Precision Medicine
What Fibonacci levels say about Camp4 Therapeutics Corporation reboundReal-Time AI Generated Market Forecast - Newser
What moving averages say about Camp4 Therapeutics CorporationMarket Liquidity and Price Flow Analysis - Newser
What makes Camp4 Therapeutics Corporation stock price move sharplyFree News Based Entry Opportunity Alerts - Newser
Why Camp4 Therapeutics Corporation stock is on top investor watchlistsFree Real Profit Trade Plan Suggestions - Newser
Should you hold or exit Camp4 Therapeutics Corporation nowEarly Entry Planner for Swing Candidates - Newser
Camp4 Therapeutics Corporation Stock Chart Analysis: Bullish or Bearish Pattern FormingReal Market Tracker with Price Action Tools - Newser
Camp4 Therapeutics Corporation Breaks Losing Streak — Is the Trend ReversingRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
Published on: 2025-07-29 23:27:14 - metal.it
P 500Free Real-Time Analysis With Entry Targets - Newser
Camp4 Therapeutics Corporation Recovers — But Is It SustainableSecure Return Focused Investment Plan Released - metal.it
Published on: 2025-07-29 12:32:00 - metal.it
Published on: 2025-07-29 11:52:31 - metal.it
What institutional investors are buying Camp4 Therapeutics Corporation stockSwing Trade Target Finder With Low Risk - Jammu Links News
How does Camp4 Therapeutics Corporation compare to its industry peersBuild wealth with high-performing stocks - Jammu Links News
Published on: 2025-07-28 07:12:21 - Newser
Camp 4 Therapeutics Corp (CAMP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.40%
0.01%
자본화:
|
볼륨(24시간):